Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.02.2023 | Case report

Piperacillin/tazobactam

Anaphylaxis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Arceri T, et al. PEDIATRIC ANAPHYLAXIS TO PIPERACILLIN-TAZOBACTAM REQUIRES FURTHER ALLERGY TESTING TO OTHER PENICILLINS DUE TO SELECTIVE SENSITIZATION. Annals of Allergy, Asthma and Immunology 129 (Suppl.): S95-S96 abstr. M044, No. 5, Nov 2022. Available from: URL: http://doi.org/10.1016/j.anai.2022.08.770 [abstract] Arceri T, et al. PEDIATRIC ANAPHYLAXIS TO PIPERACILLIN-TAZOBACTAM REQUIRES FURTHER ALLERGY TESTING TO OTHER PENICILLINS DUE TO SELECTIVE SENSITIZATION. Annals of Allergy, Asthma and Immunology 129 (Suppl.): S95-S96 abstr. M044, No. 5, Nov 2022. Available from: URL: http://​doi.​org/​10.​1016/​j.​anai.​2022.​08.​770 [abstract]
Metadaten
Titel
Piperacillin/tazobactam
Anaphylaxis: case report
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-33456-4

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antibacterials

Case report

Milrinone

Case report

Amphotericin-b

Case report

Cefazolin